Press & Media

SkinMedica to Present at Cowen and Company 30th Annual Health Care Conference

CARLSBAD, CALIF. - March 5, 2010 - SkinMedica, Inc. today announced that the Company's President and CEO, Mary Fisher, will present at the Cowen and Company 30th Annual Health Care Conference on Tuesday, March 9, 2010, at 3:00pm ET at the Boston Marriott Copley Place in Boston, Massachusetts.

Contact:
Sarah McCabe
Stern Investor Relations
212-362-1200
sarah@sternir.com

###

About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring and commercializing products that treat dermatologic conditions and improve the appearance of skin. We market and sell to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum™ and hallmark TNS Recovery Complex®. The formulations in our clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.

SkinMedica's prescription products include VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women and EpiQui® Micro Cream (4% hydroquinone) for hyperpigmentation, or "brown spots" that commonly result from aging, inflammation or sun exposure.

SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.

TNS Recovery Complex®, VANIQA®, EpiQuin® Micro, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.